Follow Us On

Facebook  X  Linkedin  YouTube
 
 
 



The Keck School of Medicine of USC has appointed Joshua A. Hirsch, MD, as chair of the Department of Radiology.




We are pleased to announce that longtime ASIPP board member Joshua A. Hirsch, MD has been appointed to serve as Keck School of Medicine Department of Radiology Chair with the University of Southern California.


Dr. Hirsch will also be nominated as the holder of the Stewart Dale Fordham, MD, Chair in Radiology at the Keck School of Medicine. Dr. Hirsch was selected from an impressive cohort of candidates in a comprehensive national search. He brings nationally recognized leadership across academic radiology, neurointerventional, health policy, quality, and multidisciplinary clinical operations.


“Dr. Hirsch, who joins us from Harvard Medical School, is a highly collaborative leader who has a track record of strengthening quality and safety, improving operational performance, and aligning clinical services with institutional priorities,” said Carolyn Meltzer, MD, Dean of the Keck School of Medicine.


Dr. Hirsch will continue to serve on the ASIPP Board as an Academic Director on the Executive Committee. 


You may learn more about this distinguished promotion by clicking here.

 

Advance Your Skills at

ASIPP’s Hands-On Workshops

Join ASIPP this August at the Medical Education & Research Institute (MERI) in Memphis, Tennessee for three hands-on educational workshops:




Each workshop offers attendees the opportunity to earn 8 CME credits while participating in practical, hands-on instruction. Attendees who participate in the Friday workshop and one Saturday workshop may earn up to 16 CMEs.


ACCOMMODATIONS

The Westin Memphis, Beale Street

170 Lt. George W Lee Ave, Memphis, TN 38103

901-334-5900


Click Here to Book Your Room

Cut-off date for special room rates: August 13, 2026.

In order to ensure you receive the discounted room block rate of $189 plus tax per night let the hotel know you are with the ASIPP workshops.


Space is limited for these workshops.

Early registration is encouraged.

FRIDAY, AUGUST 28



Ultrasound for Regenerative Medicine Hands-On Workshop



Earn 8 CMEs while gaining practical ultrasound experience focused on regenerative medicine applications.


SATURDAY, AUGUST 29



Regenerative Medicine Hands-On Cadaver Workshop

(Basic, Intermediate, & Advanced)



Earn 8 CMEs in this cadaver workshop with hands-on instruction covering regenerative medicine techniques across varying experience levels.

SATURDAY, AUGUST 29



Interventional Techniques in IPM Hands-On Cadaver Workshop

(Basic, Intermediate & PNS)


Earn 8 CMEs in this workshop focused on interventional pain management techniques and peripheral nerve stimulation applications.

Senator Bill Cassidy Is Out. He's Taking the Science With Him. 

His evidence-based approach to health policy may no longer be political viable


When Sen. Bill Cassidy, MD (R-La.), questioned Robert F. Kennedy Jr. during his confirmation hearing for health secretary last winter, many physicians and public health leaders saw something increasingly rare in American politics: a lawmaker genuinely wrestling with science, evidence, and institutional responsibility in real time.


Cassidy, a physician by training, openly acknowledged concerns about Kennedy's long history of vaccine skepticism. He cited studies. He referenced public trust. He articulated fears shared by many within medicine about what happens when scientific uncertainty is replaced by political certainty.


And then he voted yes.


That moment felt contradictory to many in healthcare. But it revealed something larger about the current state of health policy in America, and what Cassidy's departure from the Senate may ultimately mean.


Click here to read the full article.


Experimental weight loss drug retatrutide shows dramatic weight loss in clinical trial 



Amid the growing demand for GLP-1 medications for weight loss, a new experimental drug, retatrutide, stands out, according to new clinical trial results released on Thursday.


The drug led to an average weight loss of 70.3 pounds over 80 weeks in patients with obesity, with 45% of patients on 12 mg of the once-weekly injectable retatrutide losing up to 30% of their body weight, the drugmaker, Eli Lilly and Company, said in a news release.


Those results are comparable to what is seen with bariatric surgery, according to Eli Lilly, which also makes the weight loss drug Zepbound.


Click here to read the full article.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


No additional cost for ASIPP members!




Older Age Tied to Higher CT Positivity in Abdominal Pain 




A retrospective cohort study found that older adults visiting the emergency department (ED) with abdominal pain underwent CT imaging more often than younger adults and were more likely to have acute, actionable CT findings. However, older adults with serious conditions were less likely to exhibit clear abdominal tenderness, making diagnosis more difficult.


METHODOLOGY:

  • Researchers conducted a retrospective cohort analysis of data from 1169 ED visits for nontraumatic abdominal pain at a community teaching hospital in Baltimore between 2016 and 2017, including 547 younger adults (aged 18-39 years), 393 middle-aged adults (aged 40-59 years), and 229 older adults (aged 60 years or older).
  • The researchers evaluated CT use, acute actionable CT findings, hospital admissions, surgeries, and a composite of adverse outcomes (including any actionable CT findings, emergency general surgical diagnoses, hospital admissions, or surgeries).
  • The diagnostic performance of history and physical examination findings was evaluated using sensitivity and specificity analyses, and diagnostic diversity was assessed using the Herfindahl-Hirschman Index.


Click here to read the full article.


mRNA Vaccine Shows Superior Efficacy for Influenza-Like Illness in Older Adults 



A single dose of an investigational mRNA-based vaccine called mRNA-1010 vaccine showed superior efficacy to a licensed standard-dose inactivated seasonal influenza vaccine in preventing influenza-like illness among adults aged 50 years or older, with a comparable safety profile. 


METHODOLOGY:

  • This phase 3 randomized trial, conducted during the 2024-2025 Northern Hemisphere influenza season, investigated the efficacy of the mRNA-1010 vaccine — which encodes hemagglutinin glycoproteins from World Health Organization-recommended influenza strains — vs licensed standard‑dose seasonal influenza vaccines for preventing laboratory‑confirmed influenza‑like illness in adults aged 50 years or older.
  • Overall, 40,703 vaccine recipients were assigned to receive a single intramuscular dose of mRNA-1010 (n = 20,350; 37.5 μg trivalent formulation; 12.5 μg per strain) or a licensed standard‑dose inactivated seasonal influenza vaccine (n = 20,353; preferably a trivalent formulation; a quadrivalent formulation was used when a trivalent formulation was unavailable).
  • The primary endpoint was the relative vaccine efficacy of mRNA-1010 vs the standard‑dose comparator against the first episode of protocol‑defined influenza‑like illness caused by any influenza A or B strain and confirmed by using reverse transcriptase-polymerase chain reaction (RT‑PCR), assessed from 14 days after vaccination through the end of the influenza season.


Click here to read the full article.


Apply now for one of the following 2026 dates:


June 27, July 25, September 26, October 24, November 14,

& December 12



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam


August 28, 2026


  • ABIPP Part II Oral and Practical Examination

Topics that will be covered:

Caudal epidural injections; Lumbar interlaminar epidural injections; Lumbar/sacral transforaminal epidural injections; Cervical epidural injections; Thoracic epidural injections; Lumbar/sacral medial branch and L5 dorsal ramus blocks; Cervical medial branch blocks; Thoracic medial branch blocks; Lumbar/sacral facet joint nerve radiofrequency neurolysis; Cervical medial branch radiofrequency neurolysis; Thoracic medial branch radiofrequency neurolysis; Sacroiliac joint injections; Cervical sympathetic blocks; Lumbar paravertebral sympathetic blocks; Intercostal nerve blocks; Lumbar discography; Celiac plexus blocks (not Splancnic nerve blocks); Percutaneous epidural adhesiolysis; Spinal cord stimulation lead placement

Exam Dates

Our Sponsor



Buprenorphine May Prolong Ketamine’s Reduction in Suicidal Ideation 



Buprenorphine — a medication commonly used to treat opioid use disorder — prolonged the reduction in suicidal ideation following treatment with ketamine in patients with major depressive disorder (MDD).


Results of the randomized controlled trial showed that after a single infusion with ketamine, patients given low doses of buprenorphine experienced significant decreases in suicidal ideation, with a 76% reduction at week 4 compared with 43% for placebo.


This is the second trial that has shown that buprenorphine at low doses reduces suicidal ideation in MDD.


Click here to read the full article.

Our Sponsor

The Opportunity:

  • Well-established group seeking an interventional pain physician with pain fellowship training
  • Comprehensive interventional pain management program with physicians, nurse practitioners, and two Ambulatory Surgery Centers
  • Established interventional pain management practice with strong clinical and research focus
  • High-volume practice that is ethical and fully legally compliant
  • Research and publication opportunities available
  • Early and generous partnership opportunities in both the practice and ASC


The Community:

  • Excellent quality of life in a county of more than 60,000 residents, with a regional drawing area exceeding 200,000
  • High standard of living with abundant recreational and social opportunities
  • Strong public school system and a private parochial elementary school
  • Convenient location: approximately 2.5 hours to Nashville and St. Louis; 3 hours to Memphis, Louisville, and Lexington
  • Daily one-hour flights to major international hubs, including Chicago O’Hare and Houston, TX


Please email Cindy Jackson at cindy@thepainmd.com with your current CV to schedule an interview or to learn more about this practice.

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Managing Baclofen Pump Infection with an Externalized Intrathecal Catheter: A Viable Bridging Option


Michael Suarez, DO, Jordan Erdfrocht, DO, David M. Gallacher, MD, Pratima Bajaj, BS, Mustafa Broachwala, DO, Joo Won Choi, MD, and Rajiv Reddy, MD

Refractory Trigeminal Neuralgia Treatment with Cryoneurolysis in a Patient with Idiopathic Thrombocytopenic Purpura: A Case Report


Anish J. Soni, DO, and Miles R. Day, MD

Dry Tap During Bone Marrow Aspiration for Musculoskeletal Treatments: Case Report and Proposed Management Algorithm


Michael Khadavi, MD, Alex Bourguignon, MD, Jules Mercier-Ross, MD, Lina Hawari, DO, Adam M. Pourcho, DO, and Alexandre Lavigne, MD

 
 

NARRATIVE REVIEWS

Experiment-Induced Nociception in Humans with Substance Use Disorders: A Review of Psychophysical Studies


Hada Fong-ha Ieong, Ph D, and Fu Gao, MD, PhD

Technical Strategies in Spinal Cord Stimulation for Refractory Angina: A Narrative Review


Kira Wang, and David Hao

Vitamin D Supplementation in the Management of Painful Diabetic Peripheral Neuropathy: A Narrative Review


Seoyon Yang, Dong Soon Jang, and Min Cheol Chang




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!